Otsuka Gets Discovery Platform, PKU Asset In $1.3bn Jnana Acquisition
Executive Summary
Major Japanese firm picks up US drug discovery platform company Jnana in apparent bid to strengthen discovery capabilities and build its mid-stage R&D presence in the renal area.